Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21868

1.

The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.

Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y, Sjöström M, Den RB, Freedland SJ, Klein EA, Karnes RJ, Schaeffer EM, Xu M, Speers C, Nguyen PL, Ross AE, Chan JM, Cooperberg MR, Carroll PR, Davicioni E, Fong L, Spratt DE, Feng FY.

J Natl Cancer Inst. 2018 Oct 13. doi: 10.1093/jnci/djy141. [Epub ahead of print]

PMID:
30321406
2.

Finding an Immunologic Beachhead in the Prostate Cancer Microenvironment.

Madan RA, Gulley JL.

J Natl Cancer Inst. 2018 Oct 13. doi: 10.1093/jnci/djy145. [Epub ahead of print] No abstract available.

PMID:
30321404
3.

A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.

Liu L, Moke DJ, Tsai KY, Hwang A, Freyer DR, Hamilton AS, Zhang J, Cockburn M, Deapen D.

J Natl Cancer Inst. 2018 Oct 15. doi: 10.1093/jnci/djy140. [Epub ahead of print]

PMID:
30321398
4.

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Arun BK, Ausems MGEM, Azzollini J, Barouk-Simonet E, Barwell J, Belotti M, Benitez J, Berger A, Borg A, Bradbury AR, Brunet J, Buys SS, Caldes T, Caligo MA, Campbell I, Caputo SM, Chiquette J, Claes KBM, Margriet Collée J, Couch FJ, Coupier I, Daly MB, Davidson R, Diez O, Domchek SM, Donaldson A, Dorfling CM, Eeles R, Feliubadaló L, Foretova L, Fowler J, Friedman E, Frost D, Ganz PA, Garber J, Garcia-Barberan V, Glendon G, Godwin AK, Gómez Garcia EB, Gronwald J, Hahnen E, Hamann U, Henderson A, Hendricks CB, Hopper JL, Hulick PJ, Imyanitov EN, Isaacs C, Izatt L, Izquierdo Á, Jakubowska A, Kaczmarek K, Kang E, Karlan BY, Kets CM, Kim SW, Kim Z, Kwong A, Laitman Y, Lasset C, Hyuk Lee M, Won Lee J, Lee J, Lester J, Lesueur F, Loud JT, Lubinski J, Mebirouk N, Meijers-Heijboer HEJ, Meindl A, Miller A, Montagna M, Mooij TM, Morrison PJ, Mouret-Fourme E, Nathanson KL, Neuhausen SL, Nevanlinna H, Niederacher D, Nielsen FC, Nussbaum RL, Offit K, Olah E, Ong KR, Ottini L, Park SK, Peterlongo P, Pfeiler G, Phelan CM, Poppe B, Pradhan N, Radice P, Ramus SJ, Rantala J, Robson M, Rodriguez GC, Schmutzler RK, Hutten Selkirk CG, Shah PD, Simard J, Singer CF, Sokolowska J, Stoppa-Lyonnet D, Sutter C, Yen Tan Y, Teixeira RM, Teo SH, Terry MB, Mads T, Marc T, Amanda ET, Katherine MT, Nadine T, van Asperen CJ, van Engelen K, van Rensburg EJ, Wang-Gohrke S, Wappenschmidt B, Weitzel JN, Yannoukakos D; GEMO Study Collaborators; HEBON; EMBRACE, Greene MH, Rookus MA, Easton DF, Chenevix-Trench G, Antoniou AC, Goldgar DE, Olopade OI, Rebbeck TR, Huo D.

J Natl Cancer Inst. 2018 Oct 12. doi: 10.1093/jnci/djy132. [Epub ahead of print]

PMID:
30312457
5.

Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.

Trapp E, Janni W, Schindlbeck C, Jückstock J, Andergassen U, de Gregorio A, Alunni-Fabbroni M, Tzschaschel M, Polasik A, Koch JG, Friedl TWP, Fasching PA, Haeberle L, Fehm T, Schneeweiss A, Beckmann MW, Pantel K, Mueller V, Rack B, Scholz C; SUCCESS Study Group.

J Natl Cancer Inst. 2018 Oct 11. doi: 10.1093/jnci/djy152. [Epub ahead of print]

PMID:
30312434
6.

Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells.

Hamada T, Nowak JA, Masugi Y, Drew DA, Song M, Cao Y, Kosumi K, Mima K, Twombly TS, Liu L, Shi Y, da Silva A, Gu M, Li W, Nosho K, Keum N, Giannakis M, Meyerhardt JA, Wu K, Wang M, Chan AT, Giovannucci EL, Fuchs CS, Nishihara R, Zhang X, Ogino S.

J Natl Cancer Inst. 2018 Oct 11. doi: 10.1093/jnci/djy137. [Epub ahead of print]

PMID:
30312431
7.

The Role of Castration-Resistant Bmi1+Sox2+ Cells in Driving Recurrence in Prostate Cancer.

Yoo YA, Vatapalli R, Lysy B, Mok H, Desouki MM, Abdulkadir SA.

J Natl Cancer Inst. 2018 Oct 11. doi: 10.1093/jnci/djy142. [Epub ahead of print]

PMID:
30312426
8.

Strategies to Identify and Target Cells of Origin in Prostate Cancer.

Karthaus WR, Sawyers CL.

J Natl Cancer Inst. 2018 Oct 11. doi: 10.1093/jnci/djy146. [Epub ahead of print] No abstract available.

PMID:
30312421
9.

Surveillance After Treatment of Localized Breast Cancer: Time for Reappraisal?

Sparano JA, Henry NL.

J Natl Cancer Inst. 2018 Oct 11. doi: 10.1093/jnci/djy153. [Epub ahead of print] No abstract available.

PMID:
30312420
10.

Re: Black-White Breast Cancer Incidence Trends: Effects of Ethnicity.

DeSantis CE, Jemal A.

J Natl Cancer Inst. 2018 Oct 10. doi: 10.1093/jnci/djy162. [Epub ahead of print] No abstract available.

PMID:
30307580
11.

Response to DeSantis and Jemal.

Davis Lynn BC, Rosenberg PS, Anderson WF, Gierach GL.

J Natl Cancer Inst. 2018 Oct 10. doi: 10.1093/jnci/djy163. [Epub ahead of print] No abstract available.

PMID:
30307557
12.

Clinical Impact of Tumor Mutational Burden in Neuroblastoma.

Hwang WL, Wolfson RL, Niemierko A, Marcus KJ, DuBois SG, Haas-Kogan D.

J Natl Cancer Inst. 2018 Oct 10. doi: 10.1093/jnci/djy157. [Epub ahead of print]

PMID:
30307503
13.

Targeting Exercise Interventions to Patients With Cancer in Need: An Individual Patient Data Meta-Analysis.

Buffart LM, Sweegers MG, May AM, Chinapaw MJ, van Vulpen JK, Newton RU, Galvão DA, Aaronson NK, Stuiver MM, Jacobsen PB, Verdonck-de Leeuw IM, Steindorf K, Irwin ML, Hayes S, Griffith KA, Lucia A, Herrero-Roman F, Mesters I, van Weert E, Knoop H, Goedendorp MM, Mutrie N, Daley AJ, McConnachie A, Bohus M, Thorsen L, Schulz KH, Short CE, James EL, Plotnikoff RC, Arbane G, Schmidt ME, Potthoff K, van Beurden M, Oldenburg HS, Sonke GS, van Harten WH, Garrod R, Schmitz KH, Winters-Stone KM, Velthuis MJ, Taaffe DR, van Mechelen W, José Kersten M, Nollet F, Wenzel J, Wiskemann J, Brug J, Courneya KS.

J Natl Cancer Inst. 2018 Oct 9. doi: 10.1093/jnci/djy161. [Epub ahead of print]

PMID:
30299508
14.

Genome-Wide Association Study of Susceptibility Loci for Radiation-Induced Brain Injury.

Wang TM, Shen GP, Chen MY, Zhang JB, Sun Y, He J, Xue WQ, Li XZ, Huang SY, Zheng XH, Zhang SD, Hu YZ, Qin HD, Bei JX, Ma J, Mu J, Yao Shugart Y, Jia WH.

J Natl Cancer Inst. 2018 Oct 8. doi: 10.1093/jnci/djy150. [Epub ahead of print]

PMID:
30299488
15.

Corrigendum.

[No authors listed]

J Natl Cancer Inst. 2018 Oct 5. doi: 10.1093/jnci/djy191. [Epub ahead of print] No abstract available.

PMID:
30295800
16.

The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature.

Gallicchio L, Gadalla SM, Murphy JD, Simonds NI.

J Natl Cancer Inst. 2018 Oct 1;110(10):1048-1058. doi: 10.1093/jnci/djy189.

PMID:
30272225
17.

Role of MEL-18 Amplification in Anti-HER2 Therapy of Breast Cancer.

Lee JY, Joo HS, Choi HJ, Jin S, Kim HY, Jeong GY, An HW, Park MK, Lee SE, Kim WS, Son T, Min KW, Oh YH, Kong G.

J Natl Cancer Inst. 2018 Sep 27. doi: 10.1093/jnci/djy151. [Epub ahead of print]

PMID:
30265336
18.

Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy.

Carvalho LA, Teng J, Fleming RL, Tabet EI, Zinter M, de Melo Reis RA, Tannous BA.

J Natl Cancer Inst. 2018 Sep 25. doi: 10.1093/jnci/djy138. [Epub ahead of print]

PMID:
30257000
19.

Recommendations for Research and Practice to Improve Work Outcomes Among Cancer Survivors.

de Moor JS, Alfano CM, Kent EE, Norton WE, Coughlan D, Roberts MC, Grimes M, Bradley CJ.

J Natl Cancer Inst. 2018 Oct 1;110(10):1041-1047. doi: 10.1093/jnci/djy154.

PMID:
30252079
20.

Erratum.

[No authors listed]

J Natl Cancer Inst. 2018 Sep 20. doi: 10.1093/jnci/djy175. [Epub ahead of print] No abstract available.

PMID:
30247664

Supplemental Content

Loading ...
Support Center